Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 19 2019 - 08:00AM
Business Wire
Geron Corporation (Nasdaq: GERN) today reported that it has
granted a non-statutory stock option to purchase an aggregate of
100,000 shares of Geron common stock as an inducement to a
newly-hired employee in connection with commencement of employment
with the Company.
The stock option was granted on December 18, 2019 at an exercise
price of $1.44 per share, which is equal to the closing price of
Geron common stock on the date of grant. The stock option has a
10-year term and vests over four years, with 12.5% of the shares
underlying the option vesting on the six-month anniversary of
commencement of employment and the remaining shares vesting over
the following 42 months in equal installments of whole shares,
subject to continued employment with Geron through the applicable
vesting dates. The option was granted as a material inducement to
employment in accordance with Nasdaq Listing Rule 5635(c)(4) and is
subject to the terms and conditions of a stock option agreement
covering the grant and Geron’s 2018 Inducement Award Plan, which
was adopted December 14, 2018 and provides for the granting of
stock options to new employees.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
myeloid malignancies. For more information about Geron, visit
www.geron.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191219005154/en/
Suzanne Messere Investor and Media Relations investor@geron.com
media@geron.com CG Capital 877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2023 to Mar 2024